berberine has been researched along with Carcinoma, Ductal, Pancreatic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we show that treatment of pancreatic ductal adenocarcinoma (PDAC) cells (PANC-1, MiaPaCa-2) with the isoquinoline alkaloid berberine (0." | 3.80 | Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells. ( Eibl, G; Ming, M; Rozengurt, E; Sinnett-Smith, J; Soares, HP; Wang, J; Young, SH, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCubrey, JA | 1 |
| Abrams, SL | 1 |
| Steelman, LS | 1 |
| Cocco, L | 1 |
| Ratti, S | 1 |
| Martelli, AM | 1 |
| Lombardi, P | 1 |
| Gizak, A | 1 |
| Duda, P | 1 |
| Ming, M | 1 |
| Sinnett-Smith, J | 1 |
| Wang, J | 1 |
| Soares, HP | 1 |
| Young, SH | 1 |
| Eibl, G | 1 |
| Rozengurt, E | 1 |
2 other studies available for berberine and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells.
Topics: Berberine; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Humans; Pancreatic Ne | 2022 |
Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
Topics: Acetyl-CoA Carboxylase; Adenocarcinoma; AMP-Activated Protein Kinases; Animals; Berberine; Carcinoma | 2014 |